ARA 290 FAQ: Your Questions Answered
The questions below are the ones that come up specifically about ARA 290, rather than general peptide questions that apply to everything.
Overview
Common questions: how it relates to EPO, why it does not raise red blood cells, and what the innate repair receptor is.
What ARA 290 actually is
A short 11-part peptide modelled on the repair-signalling corner of EPO, built to switch on tissue repair without EPO's effect on red blood cells. It is studied around nerve comfort, inflammation, and healing.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
ARA 290 — common questions
How is ARA 290 related to EPO?
It is derived from a surface region of erythropoietin but was designed to activate only the tissue-protective innate repair receptor, not the receptor responsible for red-blood-cell production. That separation is the entire point of the molecule.
Why does it not raise red blood cells?
Full-length EPO drives erythropoiesis through the classical EPO receptor. ARA 290 engages a different receptor complex studied for repair signalling, so the erythropoietic arm is not activated in research models.
What is the innate repair receptor?
A proposed heteromeric receptor combining the EPO receptor with the beta-common receptor, associated in the literature with cytoprotective and anti-inflammatory signalling rather than blood-cell production.
Does it need acidic solvent?
No. As a short hydrophilic peptide it dissolves in plain bacteriostatic water without acidification.
What ARA 290 is studied for
Studied for selective engagement of the EPOR/beta-common receptor heteromer that mediates tissue-protective signalling, distinct from the classical erythropoietic receptor.
A substantial share of the published literature examines small-fibre and neuropathic-pain research models.
Investigated for modulation of inflammatory pathways in preclinical tissue-injury models.
Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.
More ARA 290 reference
Lyophilized and reconstituted storage conditions, plus the practical working window.
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
FAQ reference for other compounds
ARA 290 is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.